Stock Fundamentals

Company Information

Company Name
Shattuck Labs Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US82024L1035
CIK: 0001680367
CUSIP: 82024L103
Currency: USD
Full Time Employees: 40
Phone: 512 900 4690
Fiscal Year End: December
IPO Date: Oct 09, 2020
Description:

Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Address:

500 West 5th Street, Austin, TX, United States, 78701

Directors & Officers

Name Title Year Born
Dr. Taylor H. Schreiber M.D., Ph.D. Co-Founder, CEO & Director 1980
Mr. Andrew R. Neill M.B.A. Chief Financial Officer 1986
Dr. Arunthathy Nirmalini Pandite M.B.A., M.D. Chief Medical Officer 1959
Mr. Brad Huckabee Vice President of Accounting & SEC reporting NA
Dr. Abhinav A. Shukla Ph.D. Chief Technical Officer 1974
Dr. Stephen Stout J.D., Ph.D. General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer 1976
Ms. Casi DeYoung Chief Business Officer 1971
Dr. Thomas Lampkin Pharm.D. Senior Vice President of Regulatory Affairs NA
Mr. Suresh de Silva Ph.D. Chief Scientific Officer NA
Ms. Kelli Collin M.S. Senior Vice President of Quality NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Aug 25, 2025 Mona Ashiya N/A Purchase 6.31M $0.87 $5.49M
Aug 25, 2025 Orbimed Advisors Llc N/A Purchase 6.31M $0.87 $5.49M

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
T. Rowe Price Investment Management,Inc. 9.87M Mar 31, 2026 12.87% $0.04 430.08%
Orbimed Advisors, LLC 6.31M Mar 31, 2026 8.22% $0.80 0.00%
Redmile Group, LLC 5.54M Mar 31, 2026 7.22% $2.36 0.00%
Prosight Management, LP 5.00M Mar 31, 2026 6.53% $5.28 110.14%
Adage Capital Partners Gp LLC 4.64M Mar 31, 2026 6.06% $0.05 -26.34%
NEXTBio Capital Management LP 3.15M Mar 31, 2026 4.11% $9.40 0.00%
Vanguard Group Inc 2.38M Dec 31, 2025 3.10% $0.00 11.72%
T. Rowe Price Associates, Inc. 1.78M Mar 31, 2026 2.33% $0.00 -7.44%
Clark Estates Inc 1.48M Mar 31, 2026 1.92% $2.28 0.00%
Pinnacle Associates Inc 1.37M Mar 31, 2026 1.78% $0.11 1.30%
Aberdeen Group PLC 1.16M Mar 31, 2026 1.51% $0.01 118.26%
Point72 Asset Management, L.P. 1.03M Mar 31, 2026 1.34% $0.01 -3.48%
Ameriprise Financial Inc 905.71K Mar 31, 2026 1.18% $0.00 7,775.71%
683 Capital Management LLC 800.00K Mar 31, 2026 1.04% $0.27 -42.45%
Millennium Management LLC 763.75K Mar 31, 2026 1.00% $0.00 59.98%
Susquehanna International Group, LLP 715.97K Mar 31, 2026 0.93% $0.00 382.37%
Geode Capital Management, LLC 645.71K Mar 31, 2026 0.84% $0.00 4.44%
Renaissance Technologies Corp 604.50K Mar 31, 2026 0.79% $0.01 77.43%
Marshall Wace Asset Management Ltd 581.47K Mar 31, 2026 0.76% $0.00 18.69%
BlackRock Inc 510.81K Mar 31, 2026 0.67% $0.00 22.05%

Shares Statistics

Shares Outstanding: 76.68M
Shares Float: 47.71M
% Insiders: 525.80%
% Institutions: 7,319.70%
Short % Float: 1.80%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 T. Rowe Price Small-Cap Value 2.83M 3.69% ▲ 34.54% Mar 31, 2026
2 T. Rowe Price US Small-Cap Core Equity 2.02M 2.64% ▲ 0.00% Mar 31, 2026
3 T. Rowe Price Small-Cap Stock 2.02M 2.64% ▲ 0.00% Mar 31, 2026
4 T. Rowe Price U.S. SC Value Eq Tr-D 1.84M 2.40% ▲ 264.42% Mar 31, 2026
5 Vanguard Total Stock Mkt Idx Inv 1.59M 2.08% ▲ 0.00% Apr 30, 2026
6 T. Rowe Price Instl Small-Cap Stock 1.11M 1.45% ▲ 0.00% Mar 31, 2026
7 abrdn Life Sciences Investors 1.07M 1.40% ▼ 7.28% Apr 30, 2026
8 T. Rowe Price U.S. SC Core Eq Tr-D 947.86K 1.24% ▲ 0.00% Mar 31, 2026
9 Columbia Small Cap Growth 765.40K 1.00% ▲ 0.00% Mar 31, 2026
10 Columbia Small Cap Growth Inst 765.40K 1.00% ▲ 0.00% Apr 30, 2026

Valuation Metrics

Enterprise Value: $345.71M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $374.97M
EBITDA: $-48.94M
Book Value: $1.27
Earnings/Share: $-0.56
Profit Margin: 0.00%
Operating Margin: -5,258.30%
ROA (TTM): -36.66%
ROE (TTM): -61.04%
Revenue (TTM): $1.00M
Revenue/Share (TTM): $0.01
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -66.60%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 11.70x 0.00x 0.09x N/A 0.00x
2024-12-31 8.88x 0.01x 0.13x N/A -0.01x
2023-12-31 12.51x 0.01x 0.09x N/A -0.01x
2022-12-31 7.39x 0.00x 0.14x -33.62x -0.01x
2021-12-31 11.72x 0.00x 0.09x -32.80x 0.00x
2020-12-31 20.53x 0.02x 0.11x N/A -0.19x
2019-12-31 2.12x -0.10x 1.77x N/A -0.15x
2018-12-31 3.15x -0.16x 1.16x -2.34x -0.38x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about STTK.US!